Protara Therapeutics (TARA) Other Non-Current Assets (2014 - 2026)

Protara Therapeutics (TARA) has 13 years of Other Non-Current Assets data on file, last reported at $76000.0 in Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 89.8% year-over-year to $76000.0 in Q1 2026; TTM through Mar 2026 was $76000.0, a 89.8% decrease from a year earlier, with the FY2025 full-year figure at $2.9 million, up 295.97% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $76000.0, down from $2.9 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for TARA reached as high as $2.9 million in Q4 2025 and fell as low as $29000.0 in Q2 2025.
• Historically, Other Non-Current Assets has averaged $789764.7 across 5 years, with a median of $745000.0 in 2022.
• Across the five-year window, Other Non-Current Assets surged 1474.0% in 2022 and tumbled 96.11% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $644000.0 in 2022, then gained by 15.68% to $745000.0 in 2023, then changed by 0.0% to $745000.0 in 2024, then soared by 295.97% to $2.9 million in 2025, then sank by 97.42% to $76000.0 in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $76000.0 in Q1 2026, $2.9 million in Q4 2025, and $745000.0 in Q3 2025.